Skip to main content
AVBP logo

ArriVent BioPharma, Inc.

AVBPNASDAQHealthcareBiotechnology

$16.66Today:- (-)1Y −13.94%

As of Oct 16, 2026 close

Market cap
$799.32M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$11.36$35.83
Volume (live)
-
Avg. volume (3M)
1.62M

ArriVent BioPharma, Inc. (AVBP) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for ArriVent BioPharma, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
(19 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$28.36
+70.23% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AVBP Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Robert Burns
HC Wainwright
BuyReiterates
$47.00 → $27.00
Michael Schmidt
Guggenheim
BuyReiterates
$45.00 → $18.00
Jeet Mukherjee
BTIG
BuyReiterates
$42.00 → $29.00
Yigal Nochomovitz
Citi
BuyMaintains
$40.00 → $20.00
Kaveri Pohlman
Clear Street
BuyMaintains
$47.00 → $22.00
Boris Peaker
JonesTrading
BuyReiterates
$45.00 → $22.00
Jeet Mukherjee
BTIG
BuyReiterates
$42.00 → $29.00
Supawat Thongthip
Truist
BuyMaintains
$45.00 → $18.00
Kelly Shi
Jefferies
BuyMaintains
$45.00 → $18.00
Michael Schmidt
Guggenheim
BuyMaintains
$45.00
Supawat Thongthip
Truist
BuyMaintains
-
Yigal Nochomovitz
Citi
BuyMaintains
$40.00
Sam Slutsky
LifeSci Capital
BuyMaintains
$43.00
Robert Burns
HC Wainwright
BuyReiterates
$47.00
Jeet Mukherjee
BTIG
BuyMaintains
$42.00
Asthika Goonewardene
Leerink Partners
BuyMaintains
$45.00
Jeff Jones
Oppenheimer
BuyMaintains
$50.00
Boris Peaker
JonesTrading
BuyMaintains
$45.00
Jeet Mukherjee
BTIG
BuyMaintains
$42.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 8, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for AVBP?

The analyst consensus rating for AVBP is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for AVBP?

The average 12-month price target for AVBP is $28.36, representing an upside of 70.2% from the Oct 16, 2026 close of $16.66.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.